Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

FEBS Letters

Volumn 531, Issue 2, 2002, Pages 278-284

  Yamazaki, Ryuta ^a,b   Kusunoki, Natsuko ^a   Matsuzaki, Takeshi ^b   Hashimoto, Shusuke ^b   Kawai, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Akt; Apoptosis; Celecoxib; Colon cancer cells; Proliferation; Selective cyclooxygenase 2 inhibitors

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DNA FRAGMENT; ETODOLAC; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; ROFECOXIB;

APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; CASPASES; CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR CELLS, CULTURED;

EID: 0037032482     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03535-4     Document Type: Article

References (29)

1. Thun M.J., Namboodiri M.M., Heath C.W. Jr. New Engl. J. Med. 325:1991;1593-1596.
2. Giovannucci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E. New Engl. J. Med. 333:1995;609-614.
3. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.K., Levin B. New Engl. J. Med. 342:2000;1946-1952.
4. Oshima M., Murai N., Kargman S., Arguello M., Luk P., Kwong E., Taketo M., Evans J.F. Cancer Res. 61:2001;1733-1740.
5. Takahashi M., Fukutake M., Yokota S., Ishida K., Wakabayashi K., Sugimura T. J. Cancer Res. Clin. Oncol. 122:1996;219-222.
6. Kawamori T., Rao C.V., Seibert K., Reddy B.S. Cancer Res. 58:1998;409-412.
7. Yoshimi N., Shimizu M., Matsunaga K., Yamada Y., Fujii K., Hara A., Mori H. Jpn. J. Cancer Res. 90:1999;406-412.
8. Kishimoto Y., Takata N., Jinnai T., Morisawa T., Shiota G., Kawasaki H., Hasegawa J. Gut. 47:2000;812-819.
9. Piazza G.A., Rahm A.L., Krutzsch M., Sperl G., Paranka N.S., Gross P.H., Brendel K., Burt R.W., Alberts D.S., Pamukcu R., Ahnen D.J. Cancer Res. 55:1995;3110-3116.
10. Shiff S.J., Koutsos M.I., Qiao L., Rigas B. Exp. Cell Res. 222:1996;179-188.
11. Vane J.R. Nature. 231:1971;232-235.
12. Sheng H., Shao J., Kirkland S.C., Isakson P., Coffey R.J., Morrow J., Beauchamp R.D., DuBois R.N. J. Clin. Invest. 99:1997;2254-2259.
13. Souza R.F., Shewmake K., Beer D.G., Cryer B., Spechler S.J. Cancer Res. 60:2000;5767-5772.
14. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L., Shiff S.I., Rigas B. Biochem. Pharmacol. 52:1996;237-245.
15. Elder D.J., Halton D.E., Hague A., Paraskeva C. Clin. Cancer Res. 3:1997;1679-1683.
16. Smith M.L., Hawcroft G., Hull M.A. Eur. J. Cancer. 36:2000;664-674.
17. Jackson L.M., Hawkey C.J. Drugs. 59:2000;1207-1216.
18. Hara A., Yoshimi N., Niwa M., Ino N., Mori H. Jpn. J. Cancer Res. 88:1997;600-604.
19. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. Prostaglandins. 47:1994;55-59.
20. Kato M., Nishida S., Kitasato H., Sakata N., Kawai S. J. Pharm. Pharmacol. 53:2001;1679-1685.
21. Testa J.R., Bellacosa A. Proc. Natl. Acad. Sci. USA. 98:2001;10983-10985.
22. Goldman A.P., Williams C.S., Sheng H., Lamps L.W., Williams V.P., Pairet M., Morrow J.D., DuBois R.N. Carcinogenesis. 19:1998;2195-2199.
23. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cell. 93:1998;705-716.
24. Masferrer J.L., Koki A., Seibert K. Ann. New York Acad. Sci. 889:1999;84-86.
25. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. J. Biol. Chem. 272:1997;3406-3410.
26. Yamazaki R., Kusunoki N., Matsuzaki T., Hashimoto S., Kawai S. J. Pharmacol. Exp. Ther. 302:2002;18-25.
27. Seed B. Nat. Med. 4:1998;1004-1005.
28. Kitamura S., Miyazaki Y., Shinomura Y., Kondo S., Kanayama S., Matsuzawa Y. Jpn. J. Cancer Res. 90:1999;75-80.
29. Hsu A.L., Ching T.T., Wang D.S., Song X., Rangnekar V.M., Chen C.S. J. Biol. Chem. 275:2000;11397-11403.